American Regent, a member of the Daiichi Sankyo Group, announced that the first patient has been enrolled into the phase 3 clinical trial, HEART-FID. This double-blind, multicenter, prospective, randomized, placebo-controlled study will assess the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of patients with heart failure, iron deficiency and a reduced ejection fraction.

May 3, 2017 — A new study published in The Anatomical Record finds that peripheral arteries, easily accessible by ...

Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER AF) study. The study is evaluating the AcQMap High Resolution Imaging and Mapping System in patients with persistent atrial fibrillation (AF) in Europe and Canada.

The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on April 29 to address the need to standardize best practices in cardiac surgery. The session, titled “ERACS: Best Practices, Cost-Effective Initiative,” featured a consortium of forward-thinking leaders in cardiac surgery joining together as other specialties have done through their Enhanced Recovery After Surgery (ERAS) programs.

Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous coronary intervention (PCI) procedure using the CorPath GRX System to more than 4,000 attendees at the 22nd annual TCT Asia-Pacific Cardiovascular Summit.